Showing results (181-190 of 225) with videos related to
Sort By:
Pageof 23
Current Oncology (Toronto, Ont.)|February 14, 2014
Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysisI Kong, S A Narod, C Taylor, et al.Breast Cancer Research and Treatment|March 5, 2013
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysisEileen Rakovitch, Sharon Nofech-Mozes, Steven A Narod, et al.International Journal of Radiation Oncology, Biology, Physics|May 28, 2013
Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysisEileen Rakovitch, Steven A Narod, Sharon Nofech-Moses, et al.International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breastNafisha Lalani, Lawrence Paszat, Rinku Sutradhar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast RadiotherapyFei-Fei Liu, Wei Shi, Susan J Done, et al.Breast (Edinburgh, Scotland)|August 8, 2017
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomyEileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, et al.Springerplus|July 18, 2015
Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysisJonathan Klein, Iwa Kong, Lawrence Paszat, et al.Molecular Cancer Research : MCR|September 24, 2021
Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast CancerSamah El Ghamrasni, Rene Quevedo, James Hawley, et al.NPJ Breast Cancer|December 15, 2025
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancerMartin Rotbauer, Melanie Dawe, Kevin C J Nixon, et al.Cancer Research|September 25, 2015
Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer PatientsKatherine L Wright, Jessica R Adams, Jeff C Liu, et al.Pageof 23